Business
HIMSS22
Andrew Sorenson, Castell's chief analytics officer, discusses how healthcare providers can go beyond obvious uses in implementing value-based care.
Also: Oma Fertility emerges from stealth with $37.5 million in equity and debt financing, and payer data platform Abacus Insights scores $28 million.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
HIMSS22
Facilities being created now must incorporate the next 10 years of tech, says Samantha Field, public health registrar at NHS.
Also, Nordic nurse-tech pioneer to launch in the UK.
It will use the funds to deepen its presence across Asia.
The company plans to bring its technology to 10,000 more doctors in the country.
The round comes nearly a year after the company announced a $66 million Series C.
The deal will allow the company to offer a combination of in-person physical therapy and virtual coaching tools.
The all-cash deal is expected to close by the end of the year, subject to regulatory clearance.